SUBJECTIVE AND OBJECTIVE SYMPTOMS IN RELATION TO PLASMA METHADONE CONCENTRATION IN METHADONE PATIENTS

被引:35
作者
HILTUNEN, AJ [1 ]
LAFOLIE, P [1 ]
MARTEL, J [1 ]
OTTOSSON, EC [1 ]
BOREUS, LO [1 ]
BECK, O [1 ]
BORG, S [1 ]
HJEMDAHL, P [1 ]
机构
[1] KAROLINSKA HOSP,DEPT CLIN PHARMACOL,S-10401 STOCKHOLM,SWEDEN
关键词
METHADONE CONCENTRATIONS; DAILY VARIATION; RATING SCALES; HUMANS;
D O I
10.1007/BF02245829
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Two rating scales, which were originally developed for measurements of objective and subjective signs of opiate withdrawal, were used to evaluate potential estimates (correlates) of methadone effects in relation to plasma methadone concentrations. Patients participating in our regular methadone maintenance treatment project were studied during 24 h after the intake of the daily methadone dose. Methadone concentrations in plasma were compared to the subjective (estimated by the patients) and objective (estimated by the investigator) signs of the drug effects before, and 2.5, 5, 9 and 24 h after intake of methadone. Some new items possibly related to rising methadone concentrations were added to the subjective scale. Results indicated that, for subjective ratings, the majority of the items investigated corresponded well with the plasma methadone concentrations. The most significant associations were found for the following items: low psychomotor speed, alertness, running nose, yawning and anxiety. For objective ratings, only the items rhinorrhea, piloerection and signs of anxiety were significantly associated with the methadone concentrations. These rating scales may, together with plasma methadone determinations, be of considerable value when making dose adjustments for methadone maintenance patients. Further work is, however, needed to establish concentration - effect relationships.
引用
收藏
页码:122 / 126
页数:5
相关论文
共 12 条
[1]   MONITORING OF PLASMA METHADONE - INTERCORRELATION BETWEEN IMMUNOASSAY AND GAS-CHROMATOGRAPHY MASS-SPECTROMETRY [J].
BECK, O ;
BOREUS, LO ;
BORG, S ;
JACOBSSON, G ;
LAFOLIE, P ;
STENSIO, M .
THERAPEUTIC DRUG MONITORING, 1990, 12 (05) :473-477
[2]  
DOLE VP, 1991, EFFECTIVENESS METHAD, pR7
[3]  
EDWARDS AL, 1979, MULTIPLE REGRESSION
[5]  
HAERTZEN CA, 1968, DIS NERV SYST, V29, P450
[6]  
HANDELSMAN L, 1987, AM J DRUG ALCOHOL AB, V13, P293, DOI 10.3109/00952998709001515
[7]   The morphine abstinence syndrome, its nature and treatment [J].
Himmelsbach, CK .
ANNALS OF INTERNAL MEDICINE, 1941, 15 (05) :829-839
[8]  
HOLMSTRAND J, 1978, CLIN PHARMACOL THER, V23, P175
[9]  
KAZDIN AE, 1980, RES DESIGN CLIN PSYC, P302
[10]   Clinical studies of drug addiction, III A critical review of the withdrawal treatments with method of evaluating abstinence syndromes [J].
Kolb, L ;
Himmelsbach, CK .
AMERICAN JOURNAL OF PSYCHIATRY, 1938, 94 :759-799